Leishmaniasis (Kala-Azar) - Pipeline Review, H1 2017

Market: Pharmaceuticals and Healthcare

Global, 97 pages report, published by Global Markets Direct

Report ThumbnailMay-2017
Leishmaniasis (Kala-Azar) - Pipeline Review, H1 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Leishmaniasis (Kala-Azar) - Pipeline Review, H1 2017, provides an overview of the Leishmaniasis (Kala-Azar) (Infectious Disease) pipeline landscape.

Leishmaniasis is an infection caused by a parasite that is spread to people through the bite of the female phlebotomine sand fly. Symptoms include weight loss, low blood counts, enlargement of the liver

Read More
  • List of Figures
  • Number of Products under Development for Leishmaniasis (Kala-Azar), H1 2017
  • Number of Products under Development by Companies, H1 2017
  • Number of Products under Development by Universities/Institutes, H1 2017
  • Number of Products by Top 10 Targets, H1 2017
  • Number of Products by Stage and Top 10 Targets, H1 2017
  • Number of Products by Top 10 Mechanism of Actions, H1 2017
  • Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
  • Number of Products by Routes of Administration
Read More
  • List of Tables
  • Number of Products under Development for Leishmaniasis (Kala-Azar), H1 2017
  • Number of Products under Development by Companies, H1 2017
  • Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017
  • Number of Products under Development by Universities/Institutes, H1 2017
  • Products under Development by Companies, H1 2017
  • Products under Development by Companies, H1 2017 (Contd..1), H1 2017
  • Products under Development by Universities/Institutes, H1 2017
  • Products under De
Read More
  • Table of Contents
  • List of Tables
  • List of Figures
  • Introduction
  • Global Markets Direct Report Coverage
  • Leishmaniasis (Kala-Azar) - Overview
  • Leishmaniasis (Kala-Azar) - Therapeutics Development
  • Pipeline Overview
  • Pipeline by Companies
  • Pipeline by Universities/Institutes
  • Products under Development by Companies
  • Products under Development by Universities/Institutes
  • Leishmaniasis (Kala-Azar) - Therapeutics Assessment
  • Assessment by Target
  • Assessment by Mechanism of Action
  • Assessment by Route of Administra
Read More

Please select a license type

Share

Related Products

Global Markets DirectLeishmaniasis (Kala-Azar) - Pipeline Review, H1 2017Product ThumbnailLeishmaniasis (Kala-Azar) - Pipeline Review, H1 2017, Industry ReportProduct #: 797294
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2018 Global Market Analyst. All Rights Reserved